Guangyuan Hu

2.1k citations
82 papers · 1.5k indexed · h-index 20
Topics
Lung Cancer Treatments and Mutations (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)Head and Neck Cancer Studies (7 papers)

In The Last Decade

Guangyuan Hu

74 papers receiving 1.5k citations

Peers

Guangyuan Hu
Comparison fields: 5 of 146
  • Molecular Biology 421
  • Oncology 302
  • Physiology 302
  • Public Health, Environmental and Occupational Health 214
  • Pulmonary and Respiratory Medicine 198
Replace Tao Chen with:
Tao Chen China
Heather Spencer Feigelson United States
Xiaobin Zheng China
Li Peng China
Yuan Gao China
Peiyu Wang China
Xiaoling Jin United States
Shinya Saito Japan
Guangyuan Hu relative to Tao Chen China Tao Chen's profile →
Citations per field
00.5×4.3×
Tao Chen · 1×
Citations per year

Countries citing papers authored by Guangyuan Hu

Since Specialization
Citations

This map shows the geographic impact of Guangyuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyuan Hu more than expected).

Fields of papers citing papers by Guangyuan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyuan Hu. The network helps show where Guangyuan Hu may publish in the future.

Co-authorship network of co-authors of Guangyuan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyuan Hu. A scholar is included among the top collaborators of Guangyuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyuan Hu. Guangyuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 16
3 3
4 32
5 12
6 2
7 1
8 6
9 13
10 0
11 38
12 25
13 48
14 12
15 60
16 9
17 14
18 73
19 225
20
Mannich Reaction of Carboxyl alpha-H of Poly(2-Propenoic Acid) and its Application in Tanning
2

About Guangyuan Hu

Guangyuan Hu is a scholar working on Otorhinolaryngology, Oncology and Structural Biology, having authored 82 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Head and Neck Cancer Studies (7 papers). The work is most often cited by research in Cancer Research (191 citations), Physiology (302 citations) and Oncology (302 citations). Guangyuan Hu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Pekka Jousilahti, Xianglin Yuan, Aulikki Nissinen, Timo A. Lakka, Jaakko Tuomilehto, Noël C. Barengo, Heikki Pekkarinen, J Tuomilehto, Katja Borodulin and Qi Mei. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026